Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 2, Issue 2
1 February 1996
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265
Issue Sections

Minireviews

Thymidylate synthase inhibitors.
N Touroutoglou; R Pazdur
View articletitled, Thymidylate synthase inhibitors.
Open the PDF for in another window
Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins.
Y Reiter; I Pastan
View articletitled, Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins.
Open the PDF for in another window

Advances in Brief

Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
R Taetle; B Dos Santos; K Akamatsu; Y Koishihara; Y Ohsugi
View articletitled, Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Open the PDF for in another window
bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy.
O Gallo; V Boddi; A Calzolari; L Simonetti; M Trovati; S Bianchi
View articletitled, bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy.
Open the PDF for in another window
Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
S P Howard; S J Park; L Hughes-Davies; C N Coleman; B D Price
View articletitled, Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
Open the PDF for in another window
Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.
W D Tilley; G Buchanan; T E Hickey; J M Bentel
View articletitled, Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.
Open the PDF for in another window

Research Articles

Phase I trial of 9-cis retinoic acid in adults with solid tumors.
J M Kurie; J S Lee; T Griffin; S M Lippman; P Drum; M P Thomas; C Weber; M Bader; G Massimini; W K Hong
View articletitled, Phase I trial of 9-cis retinoic acid in adults with solid tumors.
Open the PDF for in another window
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma.
A A Jakubowski; D F Bajorin; M A Templeton; P B Chapman; B V Cody; H Thaler; Y Tao; D A Filippa; L Williams; M L Sherman; M B Garnick; A N Houghton
View articletitled, Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma.
Open the PDF for in another window
Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea.
P A Philip; V L Souliotis; A L Harris; A Salisbury; A D Tates; K Mitchell; J H van Delft; T S Ganesan; S A Kyrtopoulos
View articletitled, Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea.
Open the PDF for in another window
Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administration.
P Lindnér; D Heath; S Howell; P Naredi; L Hafström
View articletitled, Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administration.
Open the PDF for in another window
Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.
J H Schiller; J A Hank; M Khorsand; B Storer; A Borchert; K Huseby-Moore; D Burns; O Wesly; M R Albertini; G Wilding; P M Sondel
View articletitled, Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.
Open the PDF for in another window
Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.
M L Graham; J J Shuster; B A Kamen; V J Land; M J Borowitz; B Camitta; D L Cheo; M P Harrison; B G Leventhal; D P Pinkel; D J Pullen; P Steuber; V M Whitehead
View articletitled, Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.
Open the PDF for in another window
Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
C W Li; W G Negendank; K A Padavic-Shaller; P J O'Dwyer; J Murphy-Boesch; T R Brown
View articletitled, Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
Open the PDF for in another window
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.
R M Bukowski; T Olencki; H Gunn; D McLain; G T Budd; K Sandstrom; L Tuason; C Redovan; P Rayman; R Tubbs; D Resta; P Elson; J Finke
View articletitled, Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.
Open the PDF for in another window
Intratumor pharmacokinetics, flow resistance, and metabolism during gemcitabine infusion in ex vivo perfused human small cell lung cancer.
P E Kristjansen; T J Brown; L A Shipley; R K Jain
View articletitled, Intratumor pharmacokinetics, flow resistance, and metabolism during gemcitabine infusion in ex vivo perfused human small cell lung cancer.
Open the PDF for in another window
PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein.
U Vanhoefer; S Cao; H Minderman; K Tóth; R J Scheper; M L Slovak; Y M Rustum
View articletitled, PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein.
Open the PDF for in another window
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate.
M A Carducci; J B Nelson; K M Chan-Tack; S R Ayyagari; W H Sweatt; P A Campbell; W G Nelson; J W Simons
View articletitled, Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate.
Open the PDF for in another window
Expression of bcl-2 and the progression of human and rodent prostatic cancers.
Y Furuya; S Krajewski; J I Epstein; J C Reed; J T Isaacs
View articletitled, Expression of bcl-2 and the progression of human and rodent prostatic cancers.
Open the PDF for in another window
Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression.
G Yang; A M Stapleton; T M Wheeler; L D Truong; T L Timme; P T Scardino; T C Thompson
View articletitled, Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression.
Open the PDF for in another window
Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum.
M Lehnert; R de Giuli; P R Twentyman
View articletitled, Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum.
Open the PDF for in another window
Detection of K-ras mutations in lung carcinomas: relationship to prognosis.
P Keohavong; M A DeMichele; A C Melacrinos; R J Landreneau; R J Weyant; J M Siegfried
View articletitled, Detection of K-ras mutations in lung carcinomas: relationship to prognosis.
Open the PDF for in another window
Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.
A K El-Naggar; B L Kemp; N Sneige; K G Hurr; K Steck; Z N Tu; H A Fritsche; S E Singletary; C M Balch
View articletitled, Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.
Open the PDF for in another window
Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
M Yamada; A Tomida; H Yoshikawa; Y Taketani; T Tsuruo
View articletitled, Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
Open the PDF for in another window

Advertisement

Breaking
$500,000 Purse Announced for TBXT Drugs
B7-H4 Inhibitor Effective for Some Triple-Negative Breast Cancers
CAR-Related T-Cell Malignancies Rare, Another Study Finds
View more recent articles
Latest News
Greater Certainty of Survival Valued Over Speedier Drug Access
Keto Diet Key to Fueling CARs?
ADC for Lymphoma Elicits Near-Perfect Response Rate
View more recent articles
Research Watch
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
Glycolysis Dictates Response to Fasting-Mimicking Diet in Breast Cancer
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept